[
  {
    "uuid": "9ceee7f66ecc3ed60f545a86635aae40dfd05483",
    "url": "https://finance.sina.com.cn/money/fund/aiassistant/jzyd/2025-04-24/doc-ineuezvf9408473.shtml",
    "ord_in_thread": 0,
    "author": "sina.com.cn",
    "published": "2025-04-23T21:05:00Z",
    "title": "中欧科技成长混合C净值上涨3.76%|收益_新浪财经_新浪网",
    "text": "中欧科技成长混合型证券投资基金（简称：中欧科技成长混合C，代码018911）公布4月23日最新净值，上涨3.76%。\n中欧科技成长混合C成立于2024年2月2日，业绩比较基准为 中国战略新兴产业成份指数 收益率×70%+中证港股通综合指数(人民币)收益率×10%+银行活期存款利率(税后)×20%。该基金成立以来收益23.95%，今年以来收益5.20%，近一月收益-7.02%，近一年收益36.88%。近一年，该基金排名同类307/7823。\n基金经理为代云锋。代云锋自2023年12月20日管理（或拟管理）该基金，任职期内收益23.95%。\n最新定期报告显示，该基金前十大重仓股如下：\n股票代码 股票名称 持仓占比 持仓股数（股） 持仓市值（元） 09868 小鹏汽车-W 9.66% 61500 447.23万 00700 腾讯控股 7.82% 7900 362.33万 002475 立讯精密 7.27% 82300 336.52万 09988 阿里巴巴-W 5.79% 22700 268.13万 688608 恒玄科技 5.13% 5844 237.44万 00981 中芯国际 5.10% 55500 236.1万 002472 双环传动 4.53% 59200 209.86万 01415 高伟电子 4.18% 73000 193.38万 01810 小米集团-W 4.14% 42200 191.59万 02423 贝壳-W 3.53% 33400 163.36万\nMACD金叉信号形成，这些股涨势不错！",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "chinese",
    "sentiment": "positive",
    "categories": [
      "Economy, Business and Finance",
      "Health",
      "Lifestyle and Leisure"
    ],
    "topics": [
      "Economy, Business and Finance->business reporting and performance",
      "Economy, Business and Finance->financial service",
      "Economy, Business and Finance->investment and opinion pieces",
      "Lifestyle and Leisure->lifestyle"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": true,
    "webz_reporter": false,
    "external_links": [
      "https://finance.sina.cn/app/sfa_macd.shtml?source=pccj",
      "https://www.finance.sina.cn/app/sfa_macd.shtml?source=pccj",
      "https://finance.sina.cn/app/sfa_macd.shtml"
    ],
    "entities": {
      "persons": [],
      "locations": [],
      "organizations": []
    },
    "syndication": {
      "syndicated": null,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "trust": {
      "categories": [],
      "bias": null,
      "source": {
        "type": null,
        "city": null,
        "state": null,
        "country": null,
        "domain_type": null,
        "agency": null,
        "organization_name": null
      }
    },
    "rating": null,
    "crawled": "2025-04-24T00:13:53.707+03:00",
    "updated": "2025-04-24T00:13:53.707+03:00"
  },
  {
    "uuid": "a00fd2698a67935770706c2bd1c77c031b63c9d1",
    "url": "https://flipboard.com/topic/ronaldkoeman/royal-canadian-dragoons-celebrated-by-dutch-city-it-liberated-80-years-ago/a-NJQwhAF3S4GEYzxXGA-ZJg%3Aa%3A2486686811-e2140fe630%2Fnationalpost.com",
    "ord_in_thread": 0,
    "author": "nationalpost.com - Justine Castillo",
    "published": "2025-04-16T21:49:00Z",
    "title": "Royal Canadian Dragoons celebrated by Dutch city it liberated 80 years ago | Flipboard",
    "text": "Royal Canadian Dragoons celebrated by Dutch city it liberated 80 years ago On April 15, 1945, the Royal Canadian Dragoons (RCD) liberated the city of Leeuwarden, Netherlands. As they entered the city, rain and the sound of …\nnationalpost.com - Justine Castillo • 27m",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Human Interest",
      "Politics",
      "War, Conflict and Unrest"
    ],
    "topics": [
      "Human Interest->anniversary",
      "Politics->political development",
      "Politics->international relations",
      "Politics->defence",
      "War, Conflict and Unrest->post-war reconstruction"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": false,
    "webz_reporter": false,
    "external_links": [],
    "entities": {
      "persons": [
        {
          "name": "Justine Castillo",
          "sentiment": "none"
        }
      ],
      "locations": [],
      "organizations": []
    },
    "syndication": {
      "syndicated": false,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "trust": {
      "categories": [],
      "bias": null,
      "source": {
        "type": null,
        "city": null,
        "state": null,
        "country": null,
        "domain_type": null,
        "agency": null,
        "organization_name": null
      }
    },
    "rating": null,
    "crawled": "2025-04-17T01:19:47.207+03:00",
    "updated": "2025-04-17T01:19:47.207+03:00"
  },
  {
    "uuid": "217386546b079a800daed72ea446d64fa6209b4c",
    "url": "https://j.eastday.com/p/1746623919042585",
    "ord_in_thread": 0,
    "author": "孔文龙",
    "published": "2025-05-07T21:18:00Z",
    "title": "受\"土台风\"影响，上海明后天将迎强风大雨，陆地最大阵风7-9级",
    "text": "受“土台风”影响，上海明后天将迎强风大雨，陆地最大阵风7-9级\n2025-05-07 21:18:45\n来源:\n[东方网·纵相新闻]今天（5月7日）上海多云到晴，全市大部分地区气温在22~26℃之间。明天受江淮气旋影响强风加大雨马上来袭。江淮气旋，被称为“土台风”，是指生长在长江中下游及淮河流域区域内，具有明显冷暖锋的气旋系统。它就像一个不停旋转的天气陀螺，是造成江淮地区暴雨的重要天气系统之一。一年四季都可以发生，以春季和初夏两季出现较多。 周四（5月8日）下午到周五上午，上海市将有一次强风和明显降水过程，西部和北部的局部地区暴雨，主要降水时段出现在周四傍晚到周五早晨，周四和周五陆地最大阵风7~9级。（东方网·纵相视频 孔文龙）",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "chinese",
    "sentiment": "negative",
    "categories": [
      "Weather",
      "Environment",
      "Social Issue"
    ],
    "topics": [
      "Weather->weather warning",
      "Weather->weather phenomena",
      "Weather->weather forecast",
      "Environment->climate change",
      "Environment->natural resources",
      "Social Issue->mankind",
      "Social Issue->social condition"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": false,
    "webz_reporter": false,
    "external_links": [],
    "entities": {
      "persons": [],
      "locations": [],
      "organizations": []
    },
    "syndication": {
      "syndicated": null,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "trust": {
      "categories": [],
      "bias": null,
      "source": {
        "type": null,
        "city": null,
        "state": null,
        "country": null,
        "domain_type": null,
        "agency": null,
        "organization_name": null
      }
    },
    "rating": null,
    "crawled": "2025-05-08T00:24:37.870+03:00",
    "updated": "2025-05-07T21:31:13.000+00:00"
  },
  {
    "uuid": "adb1209d247026f4684db68e7737986cd9295e55",
    "url": "https://www.fortmorgantimes.com/2023/12/29/christian-character-counts-series-wrap-up/",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Drake Hunter",
    "published": "2023-12-30T00:55:00Z",
    "title": "Christian Character Counts: Series Wrap-Up - Fort Morgan Times",
    "text": "Are you aware that a single decision can transform your entire life? Our Christian Character Count series supporters can attest to this truth. It all begins with Christ’s first instruction — “Repent” — which embodies the Christ-like trait of humility (Matthew 4:17). By making small changes, one after the other, we can embody the trait of flexibility derived from Christ’s final command, “Make Disciples.” This enables us to move beyond our limitations and reach greater heights in who we are and what we do. It’s when we stand in this mature position in life that Christian Character Counts. In the year 2023, we unveiled the 49 traits of Christ, which are widely considered to be the ultimate embodiment of personhood, the holy grail of personhood, if you will. These traits are considered to be indispensable for navigating the challenges of a world that is marred by sin and brokenness. Without these traits, it is impossible to make sense of life, and our actions may be misguided and harmful. When we choose to ignore the divine reality or follow our own selfish desires, we create more problems for ourselves and others. Learning and applying the teachings and traits of Christ can bring you many benefits and blessings. However, if you choose not to follow these teachings, it can lead to many negative consequences, such as a lack of direction, strained relationships, and moral compromises. The biggest problem is the spiritual disconnect that occurs. The commands and their benefits are based on the personal connection you have with Christ. It is through this connection that we can deepen our relationship with God and ultimately manifest a good life through His Spirit. Disregarding these traits guarantees a spiritual disconnect in life. By adopting the qualities of Christ and allowing them to shape our character, we can lead meaningful and fulfilling lives that honor God and benefit those around us, whatever the circumstances, situation, or relationship. Jesus himself provides us with the key to developing and preserving these qualities when he says, “Every man who knows my commandments and obeys them is the man who really loves me, and every man who really loves me will himself be loved by my Father, and I too will love him and make myself known to him” (John 14:21 [Phillips]). As we approach the conclusion of the Christian Character Counts Series for the year 2023, I would like to take a moment to encourage you to thoughtfully contemplate all that has been shared during our time together. The teachings and traits we have explored throughout this series have the potential to be genuinely transformative, and I hope that you have been inspired and encouraged to implement them in your daily life. Now is the time to take action and put these valuable lessons into practice so that we may honor God and manifest a life that is guided by His Spirit. Let us embrace this opportunity to grow faithfully and become more Christlike where Christian Character Counts! With Great LOVE, Drake Hunter is the Senior Pastor at Elevating Life Church in Fort Morgan and the author of “Wonderfully Weird Living.”",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Human Interest",
      "Education",
      "Religion and Belief"
    ],
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [
        {
          "name": "christ",
          "sentiment": "none"
        }
      ],
      "organizations": [
        {
          "name": "morgan times",
          "sentiment": "negative"
        }
      ],
      "locations": []
    },
    "rating": null,
    "crawled": "2023-12-30T03:17:54.727+02:00",
    "updated": "2024-01-06T04:42:58.606+02:00"
  },
  {
    "uuid": "d8cf93dc1b6847f5aa2dbae99e96692fed40fbb1",
    "url": "https://csimarket.com/news/molecular-partners-and-orano-med-blasting-cancer-cells-with-radio-darpin-therapies2024-01-05210824",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "@CSIMarket",
    "published": "2024-01-05T22:02:00Z",
    "title": "Molecular Partners and Orano Med: Blasting Cancer Cells with Radio-DARPin Therapies",
    "text": "Molecular Partners and Orano Med: Blasting Cancer Cells with Radio-DARPin Therapies\nPublished / Modified Jan 05 2024\nCSIMarket Team / CSIMarket.com\nMolecular Partners and Orano Med Team Up to Develop Cutting-Edge Radio-DARPin Therapies to Combat CancerSwitzerland and CONCORD, Mass., and PARIS, Jan. 05, 2024 - In a significant move towards innovative cancer treatments, Molecular Partners AG and Orano Med have announced a strategic collaboration to co-develop Radio-DARPin therapeutics (RDTs). Molecular Partners, a clinical-stage biotech company known for its DARPin therapeutics, and Orano Med, a leading expert in targeted alpha therapy, aim to utilize Orano Med's 212Pb radioisotope as a payload to selectively eliminate cancer cells. Focused on advancing multiple oncology targets, with DLL3 being the first target, both parties have committed to sharing the costs of preclinical and clinical development, utilizing their unique expertise to expedite the development process.\nZURICH-SCHLIEREN,\nZURICH-SCHLIEREN,\nThe partnership between Molecular Partners and Orano Med holds great promise for revolutionizing cancer treatment. Molecular Partners' DARPin therapeutics are a groundbreaking class of custom-built protein drugs that offer enhanced specificity and potency. By combining these capabilities with Orano Med's expertise in targeted alpha therapy, which utilizes alpha radiation to precisely target cancer cells, the collaboration hopes to deliver highly effective and precise treatments for cancer patients.\nThe introduction of Radio-DARPin therapeutics signifies a major advancement in cancer therapy. Traditional cancer treatments, such as chemotherapy and radiation therapy, often lack precision and can cause significant side effects due to their non-selective nature. Radio-DARPin therapies have the potential to address these limitations by harnessing highly targeted alpha radiation payloads to specifically kill cancer cells, leaving healthy cells unharmed. This precision has the potential to not only improve patient outcomes but also minimize the often debilitating side effects associated with traditional cancer treatments.\nThe first target identified by Molecular Partners and Orano Med for their collaboration is DLL3, a protein found in certain types of cancer. DLL3 has been identified as a promising target due to its high expression in certain aggressive cancers, including small cell lung cancer and metastatic prostate cancer. By leveraging the unique capabilities of Radio-DARPin therapeutics, researchers hope to develop a highly effective treatment for patients affected by these challenging cancers.\nThe collaborative efforts between Molecular Partners and Orano Med highlight the growing importance of partnerships in the biotech and pharmaceutical industries. By combining their respective expertise and sharing the costs of development, the two companies can accelerate the translation of these groundbreaking therapies from the lab to the clinic. The agreement between the two companies demonstrates their commitment to leveraging scientific innovation for the benefit of patients in need.\nWith cancer remaining a leading cause of death worldwide, the development of targeted and precise therapies is crucial. The partnership between Molecular Partners and Orano Med represents a significant step towards advancing the field of cancer therapeutics. By harnessing the power of Radio-DARPin therapeutics and targeted alpha therapy, researchers aim to provide patients with more effective treatments that minimize side effects and improve outcomes.\nPrevious News\n<a href=\"https://csimarket.com/news/apellis_pharmaceuticals_bolsters_workforce_with_strategic_equity_inducement_grants2024-01-05210502\">\nApellis Pharmaceuticals Bolsters Workforce with Strategic Equity Inducement Grants </a> <a href=\"https://csimarket.com/news/bank-of-hawaii-corporation-to-announce-q4-2023-financial-results-and-quarterly-dividend-for-preferred-stock2024-01-05220245\">\nBank of Hawaii Corporation to Announce Q4 2023 Financial Results and Quarterly Dividend for Preferred Stock </a> <a href=\"https://csimarket.com/news/revolutionary-new-treatment-for-molluscum-contagiosum-first-fda-approved-topical-prescription-drug-zelsuvmi-takes-center2024-01-05213491\">\nRevolutionary New Treatment for Molluscum Contagiosum: First FDA-approved Topical Prescription Drug ZELSUVMI Takes Center Stage </a> <a href=\"https://csimarket.com/news/tango_therapeutics_bold_move_stock_options_unleashed_to_fuel_cancer_precision_revolution2024-01-05210507\">\nTango Therapeutics' Bold Move: Stock Options Unleashed to Fuel Cancer Precision Revolution </a> <a href=\"https://csimarket.com/news/tempest_therapeutics_grants_nonqualified_stock_options_to_foster_employee_retention_and_drive_future_growth2024-01-05210503\">\nTempest Therapeutics Grants Nonqualified Stock Options to Foster Employee Retention and Drive Future Growth </a> <a href=\"https://csimarket.com/news/grupo-aeroportuario-del-pacifico-sees-significant-growth-in-passenger-traffic-defying-global-trends2024-01-05211817\">\nGrupo Aeroportuario del Pacifico Sees Significant Growth in Passenger Traffic, Defying Global Trends </a> <a href=\"https://csimarket.com/news/molecular-partners-and-orano-med-blasting-cancer-cells-with-radio-darpin-therapies2024-01-05210824\">\nMolecular Partners and Orano Med: Blasting Cancer Cells with Radio-DARPin Therapies </a> <a href=\"https://csimarket.com/news/general-dynamics-prepares-for-leadership-transition-as-mark-roualet-announces-retirement2024-01-05183866\">\nGeneral Dynamics Prepares for Leadership Transition as Mark Roualet Announces Retirement </a> <a href=\"https://csimarket.com/news/gold-reserve-prepares-for-a-smooth-transition-as-timm-passes-the-torch-to-coleman2024-01-05163246\">\nGold Reserve Prepares for a Smooth Transition as Timm Passes the Torch to Coleman </a> <a href=\"https://csimarket.com/news/gogo-business-aviation-bids-farewell-to-long-time-board-member-amidst-improved-financial-performance2024-01-05142993\">\nGogo Business Aviation Bids Farewell to Long-Time Board Member Amidst Improved Financial Performance </a>\nPrevious News\n<a href=\"https://csimarket.com/news/apellis_pharmaceuticals_bolsters_workforce_with_strategic_equity_inducement_grants2024-01-05210502\">\nApellis Pharmaceuticals Bolsters Workforce with Strategic Equity Inducement Grants </a> <a href=\"https://csimarket.com/news/bank-of-hawaii-corporation-to-announce-q4-2023-financial-results-and-quarterly-dividend-for-preferred-stock2024-01-05220245\">\nBank of Hawaii Corporation to Announce Q4 2023 Financial Results and Quarterly Dividend for Preferred Stock </a> <a href=\"https://csimarket.com/news/revolutionary-new-treatment-for-molluscum-contagiosum-first-fda-approved-topical-prescription-drug-zelsuvmi-takes-center2024-01-05213491\">\nRevolutionary New Treatment for Molluscum Contagiosum: First FDA-approved Topical Prescription Drug ZELSUVMI Takes Center Stage </a> <a href=\"https://csimarket.com/news/tango_therapeutics_bold_move_stock_options_unleashed_to_fuel_cancer_precision_revolution2024-01-05210507\">\nTango Therapeutics' Bold Move: Stock Options Unleashed to Fuel Cancer Precision Revolution </a> <a href=\"https://csimarket.com/news/tempest_therapeutics_grants_nonqualified_stock_options_to_foster_employee_retention_and_drive_future_growth2024-01-05210503\">\nTempest Therapeutics Grants Nonqualified Stock Options to Foster Employee Retention and Drive Future Growth </a> <a href=\"https://csimarket.com/news/grupo-aeroportuario-del-pacifico-sees-significant-growth-in-passenger-traffic-defying-global-trends2024-01-05211817\">\nGrupo Aeroportuario del Pacifico Sees Significant Growth in Passenger Traffic, Defying Global Trends </a> <a href=\"https://csimarket.com/news/molecular-partners-and-orano-med-blasting-cancer-cells-with-radio-darpin-therapies2024-01-05210824\">\nMolecular Partners and Orano Med: Blasting Cancer Cells with Radio-DARPin Therapies </a> <a href=\"https://csimarket.com/news/general-dynamics-prepares-for-leadership-transition-as-mark-roualet-announces-retirement2024-01-05183866\">\nGeneral Dynamics Prepares for Leadership Transition as Mark Roualet Announces Retirement </a> <a href=\"https://csimarket.com/news/gold-reserve-prepares-for-a-smooth-transition-as-timm-passes-the-torch-to-coleman2024-01-05163246\">\nGold Reserve Prepares for a Smooth Transition as Timm Passes the Torch to Coleman </a> <a href=\"https://csimarket.com/news/gogo-business-aviation-bids-farewell-to-long-time-board-member-amidst-improved-financial-performance2024-01-05142993\">\nGogo Business Aviation Bids Farewell to Long-Time Board Member Amidst Improved Financial Performance </a>",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Health",
      "Science and Technology"
    ],
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [
        {
          "name": "modi",
          "sentiment": "negative"
        }
      ],
      "organizations": [
        {
          "name": "molecular partners",
          "sentiment": "negative"
        },
        {
          "name": "radio-darpin therapies molecular partners",
          "sentiment": "negative"
        },
        {
          "name": "molecular partners ag",
          "sentiment": "none"
        },
        {
          "name": "csimarket.com molecular partners",
          "sentiment": "none"
        },
        {
          "name": "orano med",
          "sentiment": "none"
        }
      ],
      "locations": [
        {
          "name": "mass.",
          "sentiment": "none"
        },
        {
          "name": "orano med",
          "sentiment": "none"
        },
        {
          "name": "concord",
          "sentiment": "none"
        },
        {
          "name": "paris",
          "sentiment": "none"
        },
        {
          "name": "schlieren",
          "sentiment": "none"
        },
        {
          "name": "orano med team up",
          "sentiment": "none"
        },
        {
          "name": "zurich",
          "sentiment": "none"
        }
      ]
    },
    "rating": null,
    "crawled": "2024-01-06T00:46:54.521+02:00",
    "updated": "2024-01-06T00:46:54.521+02:00"
  },
  {
    "uuid": "d089f52c9cf0ac17e09bc62b373a3f33a8939dba",
    "url": "https://investorshangout.com/intellia-therapeutics-faces-class-action-lawsuit-from-investors-220947-",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Kelly Martin",
    "published": "2025-02-20T23:00:00Z",
    "title": "Intellia Therapeutics Faces Class Action Lawsuit from Investors",
    "text": "Intellia Therapeutics Faces Class Action Lawsuit from Investors\nKelly MartinUpdated: 02-20-2025 06:00 PM\nOverview of the Class Action Against Intellia Therapeutics\nIntellia Therapeutics, Inc. (NASDAQ: NTLA) is currently facing a class action lawsuit from investors, alleging that the company misled them regarding the viability of its experimental drug candidate, NTLA-3001. Investors who acquired Intellia shares between June 30, 2024, and January 28, 2025, are included in this class action, which aims to hold the company accountable for its statements during that period.\nUnderstanding the Allegations\nThe class action lawsuit is driven by a series of statements made by Intellia regarding the progress and potential of NTLA-3001, a treatment aimed at addressing alpha-1 antitrypsin deficiency (AATD)-associated lung disease. It was claimed that the company was confident in its timeline for clinical studies, expecting to dose the first patient by the second half of 2024. However, the legal complaint asserts that this information was misleading, as the company failed to disclose critical information regarding the dwindling demand for its viral-based gene editing methods.\nThe Shift in Gene Editing Methods\nAccording to the lawsuit, non-viral delivery methodologies were gaining traction in the research community due to their cost-effectiveness and efficiency in development. This shift made Intellia’s NTLA-3001 program less viable, yet the company maintained an optimistic outlook that obscured these mounting challenges.\nThe Market Reaction\nThe truth came to light for investors on January 9, 2025, when Intellia announced a significant reorganization strategy, including a halt to all research on NTLA-3001 and a workforce reduction of 27%. This drastic decision contributed to a nearly 15% drop in Intellia's stock price, signifying a major blow to both investors and the company itself.\nNext Steps for Investors\nInvestors who hold shares in Intellia Therapeutics are encouraged to evaluate their options, as they may qualify to participate in the class action lawsuit. Those interested in taking a more active role could consider serving as lead plaintiff, which involves representing the broader group of class members. It's crucial to understand that opting not to join the lawsuit still protects your rights to recover any potential losses.\nHow to Get Involved\nPotential lead plaintiffs can reach out to legal representatives at Robbins LLP to discuss their involvement. They emphasize that shareholders do not incur any fees unless a recovery is achieved, demonstrating their commitment to supporting investors in enforcing their rights.\nAbout Robbins LLP\nRobbins LLP is dedicated to protecting shareholder rights and has been instrumental in helping investors recover losses and improve corporate governance since 2002. Their experienced lawyers guide clients through the complex legal landscape following any financial misconduct. Anyone interested in the class action can connect with Robbins LLP for further information and assistance.\nFrequently Asked Questions\nWhat is the nature of the lawsuit against Intellia Therapeutics?\nThe lawsuit claims Intellia misled investors regarding the viability of its drug candidate NTLA-3001, leading to significant financial losses during its stock's decline.\nHow can I participate in the class action?\nEligible shareholders can contact Robbins LLP to learn about their rights and options for participating in the class action lawsuit.\nWhat led to the stock's decline?\nIntellia's announcement of halting research for NTLA-3001 and restructuring, which resulted in a substantial workforce reduction, triggered a negative market reaction.\nWhat does being a lead plaintiff involve?\nA lead plaintiff represents the interests of the class in the litigation process and can help guide the case based on their experience and involvement.\nAre there any costs involved in joining the lawsuit?\nShareholders seeking to join the lawsuit must not pay any fees unless there’s a successful recovery, reflecting Robbins LLP's contingency fee structure.\nAbout The Author\nContact Kelly Martin privately here. Or send an email with ATTN: Kelly Martin as the subject to contact@investorshangout.com.\nAbout Investors Hangout\nInvestors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/\nThe content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "negative",
    "categories": [
      "Economy, Business and Finance",
      "Crime, Law and Justice",
      "Health"
    ],
    "topics": [
      "Economy, Business and Finance->business governance",
      "Economy, Business and Finance->financial service",
      "Crime, Law and Justice->corporate crime",
      "Health->health organisation",
      "Health->medical profession"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": false,
    "webz_reporter": false,
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": []
    },
    "syndication": {
      "syndicated": false,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "trust": null,
    "rating": null,
    "crawled": "2025-02-21T01:03:48.057+02:00",
    "updated": "2025-02-21T01:03:48.057+02:00"
  },
  {
    "uuid": "959568a538d6aa632f0f7c1e657a08ecfcc562b8",
    "url": "https://www.rttnews.com/3437029/first-pig-kidney-transplant-patient-discharged-from-hospital-after-successful-transplant.aspx",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "RTTNews Staff Writer",
    "published": "2024-04-04T19:06:00Z",
    "title": "First Pig Kidney Transplant Patient Discharged From Hospital After Successful Transplant",
    "text": "On March 16th, a medical team at Massachusetts General Hospital achieved a groundbreaking milestone in the field of transplantation by performing the first-ever living recipient transplant of a genetically modified pig kidney.\nThe recipient, Richard Slayman, is a 62-year-old man who has been suffering from end-stage kidney disease. The successful surgery marks a significant advancement in medical science as it opens up a new avenue for organ transplantation that could help save countless lives in the future.\nThe transplant procedure involved using a pig kidney that had undergone 69 genetic modifications, removing harmful pig genes, and introducing specific human genes to enhance compatibility with humans. The kidney was donated by eGenesis in Cambridge and genetically modified using CRISPR-Cas9 technology . Additionally, the pig kidney was subjected to further modifications to eliminate the risk of infection in humans by deactivating porcine endogenous retroviruses.\nThe hospital attributed the triumph of the procedure to years of research, preclinical studies, and collaborative efforts by a team of medical professionals led by Dr. Leonardo V. Riella, Dr. Tatsuo Kawai, and Dr. Nahel Elias.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Health"
    ],
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [
        {
          "name": "richard slayman",
          "sentiment": "none"
        }
      ],
      "organizations": [
        {
          "name": "massachusetts general hospital",
          "sentiment": "negative"
        }
      ],
      "locations": [
        {
          "name": "cambridge",
          "sentiment": "none"
        }
      ]
    },
    "rating": null,
    "crawled": "2024-04-05T01:26:58.889+03:00",
    "updated": "2024-04-05T01:26:58.889+03:00"
  },
  {
    "uuid": "4ba35d6b8406a96d9c5911786597db6c420e9006",
    "url": "https://www.masslive.com/weather-alerts/2024/11/fire-warning-affecting-12-massachusetts-counties-until-friday-evening.html",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Advance Local Weather Alerts",
    "published": "2024-11-01T19:29:00Z",
    "title": "Fire warning affecting 12 Massachusetts counties until Friday evening",
    "text": "On Friday at 3:25 p.m. the National Weather Service issued a red flag warning in effect until 7 p.m. for Northern Worcester and Southern Worcester as well as Franklin, Middlesex, Essex, Hampshire, Hampden, Norfolk, Suffolk, Bristol, Plymouth, Barnstable, Dukes and Nantucket counties. Winds are forecasted to be west 10 to 20 mph with gusts up to 35 mph and relative humidity as low as 41 percent. \"Any fire that develops will catch and spread quickly. Outdoor burning is not recommended,\" says the weather service. What does a red flag warning indicate? A red flag warning signifies that either extreme fire weather conditions are currently in effect or will be shortly, as stated by the weather service. Warm temperatures, very low humidities, and stronger winds are expected to combine to produce an increased risk of fire to spread rapidly. So, what should you do under a red flag warning? A red flag warning demands vigilance and immediate readiness to respond to potential fires. The weather service provides these vital guidelines to minimize fire hazards and ensure your safety: 1. Bolster burn barrel safety: - In areas where controlled burning is sanctioned, make certain that burn barrels sport a weighty metal cover, equipped with holes no larger than 3/4 of an inch. 2. Mindful disposal of smoking materials: - Steer clear of haphazardly discarding lit cigarette butts and avoid flinging cigarettes or matches from moving vehicles. These innocuous-seeming actions can kindle dry vegetation, potentially spawning a wildfire. 3. Properly extinguish outdoor fires: - To thwart accidental fires, diligently extinguish all outdoor fires. Suffocate them with an ample deluge of water and stir to ensure complete cooling. Submerge charcoal in water until it's entirely devoid of heat. Never leave live charcoal unattended. 4. Never leave fires unattended: - Avoid abandoning any fire without supervision. Even minor sparks or drifting embers can incite nearby foliage or grass, setting off a rapidly spreading fire. Understanding the gravity of a red flag warning and adhering to these precautions is pivotal in mitigating the risk of wildfires during these perilous conditions. Prioritize safety, stay well-informed, and act responsibly to safeguard lives and property. Advance Local Weather Alerts is a service provided by United Robots, which uses machine learning to compile the latest data from the National Weather Service.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "negative",
    "categories": [
      "Weather",
      "Disaster and Accident",
      "Social Issue"
    ],
    "ai_allow": true,
    "canonical": false,
    "webz_reporter": false,
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": []
    },
    "syndication": {
      "syndicated": false,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "rating": null,
    "crawled": "2024-11-01T22:13:58.211+02:00",
    "updated": "2024-11-01T22:13:58.211+02:00"
  },
  {
    "uuid": "0440c97421074d1f6662afd1c3f1a8dcd8162eaa",
    "url": "https://www.ainvest.com/news/tron-surpasses-200-day-average-23-institutional-interest-grows-2507/",
    "ord_in_thread": 0,
    "author": "Coin World",
    "published": "2025-07-31T03:52:00Z",
    "title": "Tron Surpasses 200-Day Average by 23% as Institutional Interest Grows",
    "text": "Tron Surpasses 200-Day Average by 23% as Institutional Interest Grows\nThe integration of blockchain and gaming is evolving rapidly, with crypto betting platforms like Spartans redefining user control and accessibility. As the broader crypto market sees movements in projects such as Tron (TRX) and Kaspa (KAS), investors are increasingly drawn to networks that offer tangible utility and innovation. Spartans mirrors this trend by providing a decentralized, permissionless gaming environment, aligning with the ethos of DeFi and the expectations of Web3 users.\nTron (TRX) has seen a notable upward trend, currently trading above $0.32 and surpassing its 200-day moving average by nearly 23%. This momentum has been fueled by a $100 million reverse merger and the recent Nasdaq Opening Bell event on July 24, which enhanced its institutional credibility. Additionally, a U.S. spot TRX ETF filing by Canary Capital is expected to attract further regulated capital to the network if approved. TRON’s leading role in stablecoin transactions, particularly in USDT circulation, highlights its real-world utility. Analysts project a short-term price range of $0.33–$0.36, with more optimistic forecasts reaching as high as $0.44–$0.56, contingent on sustained volume and institutional interest.\nKaspa (KAS) has experienced a 41% rise in the past month, currently trading around $0.105. Despite this, it remains about 46% below its August 2024 peak of $0.207. Analysts anticipate a short-term consolidation with support levels between $0.075 and $0.096. Long-term forecasts, however, remain optimistic, with estimates suggesting a potential rebound to $0.18–$0.19 by year-end and as high as $0.22 under favorable market conditions. Kaspa’s innovative blockDAG architecture provides faster confirmations and higher scalability, making it an attractive option for developers and investors alike.\nSpartans is emerging as a key player in the crypto gaming space by eliminating traditional casino constraints such as KYC checks, delayed withdrawals, and transaction limits. Instead, the platform allows users to connect their crypto wallets and play immediately using BTC, ETH, USDT, USDC, AVAX, or ADA. This permissionless approach aligns with the core principles of DeFi, emphasizing instant access, autonomy, and transparency. The platform’s appeal lies in its commitment to user control, with no hidden fees or payout restrictions. It reflects the growing demand for a gaming experience that mirrors the freedom and flexibility offered by blockchain technology elsewhere.\nAs institutional interest in crypto expands, projects with real-world applications like TRON and Kaspa continue to attract attention. Similarly, Spartans is capitalizing on the demand for decentralized, user-centric platforms in the gaming sector. These developments underscore a broader shift toward utility-driven innovation in both finance and entertainment, with blockchain technology serving as the bridge.\nSource: [1] The Future of Crypto Gaming – Here’s Why Tron & Kaspa Traders are Picking Spartans for Online Betting (https://coinmarketcap.com/community/articles/688ae5095351ea6fce536047/)\nComments\nNo comments yet",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Science and Technology"
    ],
    "topics": [
      "Science and Technology->technology and engineering",
      "Science and Technology->scientific innovation"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": null,
    "webz_reporter": false,
    "external_links": [],
    "external_images": [],
    "internal_images": [],
    "entities": {
      "persons": [],
      "locations": [],
      "organizations": [
        {
          "name": "Canary Capital",
          "sentiment": "none",
          "tickers": []
        }
      ]
    },
    "syndication": {
      "syndicated": false,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "trust": {
      "categories": [],
      "top_news": [],
      "bias": null,
      "source": {
        "type": null,
        "city": null,
        "state": null,
        "country": null,
        "domain_type": null,
        "agency": null,
        "organization_name": null
      }
    },
    "rating": null,
    "crawled": "2025-07-31T07:56:26.027+03:00",
    "updated": "2025-07-31T08:00:19.000+03:00"
  },
  {
    "uuid": "5464f4ec38dc9704d42fb2c067c07326414bd7e8",
    "url": "https://denvergazette.com/outtherecolorado/news/lowest-temperature-in-country-recorded-in-colorado-at--19-degrees/article_bc456df6-a5d1-11ee-9398-23a9b1a2ea26.html",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Spencer McKee",
    "published": "2023-12-28T05:00:00Z",
    "title": "Lowest temperature in country recorded in Colorado at -19 degrees | outtherecolorado.com",
    "text": "According to the National Weather Service, a point four miles northwest of Grand Lake hit a temperature of negative 19 degrees Fahrenheit last night, which was the lowest official temperature recorded during the past 24 hours in the lower 48 states of America. The temperature of negative 19 was a full 100 degrees lower than a temperature of 81 degrees that was recorded on Wednesday near Ochopee, Florida. That being said, some estimates point to other parts of Colorado reaching temperatures even lower than that. The National Weather Service noted that the Hebron area may have reached an estimated -27 degrees via a CoAgMet data source. Several other places in the valleys of Middle and North Park also reached a similar temperature. The unique topography of Colorado can be a contributing factor when it comes to temperatures reaching an extreme cold, as cold air can get trapped in mountain valleys. The San Luis Valley is another part of the state where this effect is commonly seen during winter months.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "negative",
    "categories": [
      "Weather",
      "Environment",
      "Disaster and Accident"
    ],
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [
        {
          "name": "national weather service",
          "sentiment": "negative"
        }
      ],
      "locations": [
        {
          "name": "grand lake",
          "sentiment": "none"
        },
        {
          "name": "colorado",
          "sentiment": "none"
        },
        {
          "name": "middle and north park",
          "sentiment": "none"
        },
        {
          "name": "san luis valley",
          "sentiment": "none"
        },
        {
          "name": "hebron",
          "sentiment": "none"
        },
        {
          "name": "america",
          "sentiment": "none"
        },
        {
          "name": "ochopee",
          "sentiment": "none"
        },
        {
          "name": "florida",
          "sentiment": "none"
        }
      ]
    },
    "rating": null,
    "crawled": "2023-12-29T05:12:34.980+02:00",
    "updated": "2023-12-29T05:12:34.980+02:00"
  }
]